Virbac SA (EPA:VIRP) Investors Are Less Pessimistic Than Expected
May 18
Have your own idea? Try our Stock Screener
French (CAC) Healthcare Sector Analysis
UpdatedJun 05, 2025
DataAggregated Company Financials
Companies59
- 7D-2.7%
- 3M-12.2%
- 1Y4.2%
- YTD0.1%
Over the last 7 days, the Healthcare industry has dropped 3.8%, driven by a pullback from Sanofi of 6.5%. Over the past 12 months, the industry was up 5.0%. Earnings are forecast to grow by 14% annually.
Sector Valuation and Performance
Has the French Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 05 Jun 2025 | €282.0b | €112.6b | €9.0b | 23.2x | 31.4x | 2.5x |
| Sat, 03 May 2025 | €303.4b | €112.6b | €8.9b | 23.1x | 34x | 2.7x |
| Mon, 31 Mar 2025 | €311.5b | €111.3b | €10.1b | 21.8x | 30.9x | 2.8x |
| Wed, 26 Feb 2025 | €322.0b | €110.9b | €9.9b | 24.7x | 32.6x | 2.9x |
| Fri, 24 Jan 2025 | €304.1b | €113.9b | €9.1b | 20.1x | 33.5x | 2.7x |
| Sun, 22 Dec 2024 | €279.4b | €113.9b | €9.1b | 21.7x | 30.9x | 2.5x |
| Tue, 19 Nov 2024 | €276.5b | €113.9b | €9.1b | 21.3x | 30.5x | 2.4x |
| Thu, 17 Oct 2024 | €286.6b | €112.6b | €8.8b | 23.1x | 32.5x | 2.5x |
| Sat, 14 Sep 2024 | €288.1b | €112.0b | €8.6b | 22x | 33.7x | 2.6x |
| Mon, 12 Aug 2024 | €276.8b | €111.8b | €8.6b | 22.9x | 32.3x | 2.5x |
| Wed, 10 Jul 2024 | €262.6b | €110.0b | €9.0b | 22.9x | 29x | 2.4x |
| Fri, 07 Jun 2024 | €274.3b | €110.0b | €9.0b | 25.1x | 30.4x | 2.5x |
| Sun, 05 May 2024 | €269.9b | €104.9b | €7.6b | 23.9x | 35.6x | 2.6x |
| Tue, 02 Apr 2024 | €278.7b | €104.7b | €8.6b | 21x | 32.4x | 2.7x |
| Thu, 29 Feb 2024 | €268.3b | €104.2b | €8.9b | 20.7x | 30x | 2.6x |
| Sat, 27 Jan 2024 | €264.7b | €104.0b | €12.7b | 21.2x | 20.9x | 2.5x |
| Mon, 25 Dec 2023 | €261.9b | €104.0b | €12.7b | 21.2x | 20.6x | 2.5x |
| Wed, 22 Nov 2023 | €248.0b | €104.0b | €12.7b | 20.4x | 19.5x | 2.4x |
| Fri, 20 Oct 2023 | €256.7b | €104.8b | €12.5b | 18.7x | 20.6x | 2.5x |
| Sun, 17 Sep 2023 | €279.2b | €104.8b | €12.4b | 21.4x | 22.6x | 2.7x |
| Tue, 15 Aug 2023 | €274.4b | €104.5b | €12.5b | 21.3x | 22x | 2.6x |
| Thu, 13 Jul 2023 | €262.4b | €103.8b | €12.4b | 19.6x | 21.1x | 2.5x |
| Sat, 10 Jun 2023 | €265.1b | €108.3b | €12.1b | 20x | 21.9x | 2.4x |
| Mon, 08 May 2023 | €280.9b | €108.3b | €12.1b | 21.6x | 23.3x | 2.6x |
| Wed, 05 Apr 2023 | €268.3b | €107.8b | €12.4b | 19.9x | 21.6x | 2.5x |
| Fri, 03 Mar 2023 | €259.7b | €107.7b | €12.8b | 19.5x | 20.3x | 2.4x |
| Sun, 29 Jan 2023 | €263.7b | €104.9b | €10.5b | 18.2x | 25.1x | 2.5x |
| Tue, 27 Dec 2022 | €264.8b | €104.9b | €10.5b | 17.8x | 25.2x | 2.5x |
| Thu, 24 Nov 2022 | €266.0b | €105.0b | €10.2b | 18.2x | 26x | 2.5x |
| Sat, 22 Oct 2022 | €245.6b | €102.5b | €10.4b | 17.4x | 23.7x | 2.4x |
| Mon, 19 Sep 2022 | €182.7b | €79.2b | €9.0b | 17.7x | 20.2x | 2.3x |
| Wed, 17 Aug 2022 | €200.1b | €78.8b | €9.0b | 21.7x | 22.1x | 2.5x |
| Fri, 15 Jul 2022 | €208.3b | €76.6b | €9.1b | 19.9x | 23x | 2.7x |
| Sun, 12 Jun 2022 | €204.2b | €76.4b | €9.2b | 18.7x | 22.2x | 2.7x |
Price to Earnings Ratio
22.2x
Current Industry PE
- Investors are optimistic on the French Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 31.4x which is higher than its 3-year average PE of 26.4x.
- The industry is trading close to its 3-year average PS ratio of 2.5x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 14% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the French Healthcare sector?
| FR Market | 0.23% | |
| Healthcare | -2.69% | |
| Healthtech | 2.09% | |
| Healthcare Services | 1.37% | |
| Life Sciences | 0.75% | |
| Biotech | 0.43% | |
| Medical Equipment | -1.21% | |
| Pharma | -5.22% | |
Industry PE
- Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 26.8x.
- Analysts are expecting annual earnings growth of 28.8%, which is higher than its past year's earnings growth of 5.8% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 67% over the next 5 years.
- This is better than its past earnings growth rate of 19% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 12% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BIM bioMérieux | €120.50 | 3.0% +€412.8m | 26.2% | PE32.9x | |
| EL EssilorLuxottica Société anonyme | €245.50 | -0.9% €193.0m | 18.1% | PE47.9x | |
| IPN Ipsen | €104.10 | 1.8% +€148.9m | -15.2% | PE24.2x | |
| ABVX ABIVAX Société Anonyme | €7.01 | 34.0% +€112.9m | -45.0% | PS41.9x | |
| DIM Sartorius Stedim Biotech | €193.85 | 0.6% +€107.0m | 4.0% | PE92.3x |